Verma Abhimanyu 4

What Happened
Abhimanyu Verma, Chief Technology Officer of SOPHiA GENETICS SA, sold a total of 3,549 shares in two open-market transactions to satisfy tax withholding on vested restricted stock units. On 2026-04-06 he sold 2,519 shares at a weighted average price of $4.86 for proceeds of $12,240; on 2026-04-07 he sold 1,030 shares at a weighted average price of $4.87 for proceeds of $5,016. Combined proceeds totaled $17,256. These were sales (not purchases), typically considered routine when done for tax withholding.

Key Details

• Transaction dates and prices:
  • 2026-04-06: 2,519 shares @ weighted avg $4.86 (range $4.71–$4.95) — $12,240 (F2)
  • 2026-04-07: 1,030 shares @ weighted avg $4.87 (range $4.74–$4.96) — $5,016 (F3)
• Total: 3,549 shares sold for $17,256.
• Shares owned after transaction: Not specified in the filing.
• Footnotes: Sales were effected in the open market to satisfy tax withholding on RSU vesting (April 2–3, 2026) and executed under a pre-established Rule 10b5-1 trading plan (non-discretionary) (F1). Weighted-average prices reflect multiple trades; per-share breakdowns can be provided upon written request (F2, F3).
• Timeliness: Filed April 8, 2026; appears timely (Form 4 is generally due within two business days).

Context
These sales were reported as tax-withholding transactions under a pre-set 10b5-1 plan, which means they were routine and not discretionary trades by the insider. For retail investors, purchases by insiders can be more informative about sentiment than routine tax-related sales; this filing alone does not indicate a change in the insider’s view of company prospects.